Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,436 | 359 | 99.6% |
| Education | $23.19 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $941.17 | 70 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $467.52 | 44 | $0 (2021) |
| Amgen Inc. | $427.81 | 28 | $0 (2022) |
| PFIZER INC. | $369.98 | 23 | $0 (2024) |
| ABBVIE INC. | $368.60 | 27 | $0 (2024) |
| Lilly USA, LLC | $327.41 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $289.50 | 22 | $0 (2024) |
| Esperion Therapeutics, Inc. | $238.03 | 6 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $228.68 | 17 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $176.53 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $493.66 | 26 | Novo Nordisk Inc ($97.62) |
| 2023 | $906.76 | 50 | Novo Nordisk Inc ($288.11) |
| 2022 | $174.58 | 11 | Antares Pharma, Inc. ($41.03) |
| 2021 | $474.45 | 26 | Esperion Therapeutics, Inc. ($123.60) |
| 2020 | $309.66 | 16 | Esperion Therapeutics, Inc. ($114.43) |
| 2019 | $973.97 | 75 | Amgen Inc. ($166.81) |
| 2018 | $1,049 | 75 | Novo Nordisk Inc ($155.48) |
| 2017 | $1,077 | 84 | Janssen Pharmaceuticals, Inc ($178.58) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Gastroenterology | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: PAIN | ||||||
| 07/17/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: VACCINES | ||||||
| 06/27/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ADHD | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: VACCINES | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Cardiovascular | ||||||
| 04/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Biological | ||||||
| 03/27/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: VACCINE | ||||||
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes Care | ||||||
| 03/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Biological | ||||||
| 01/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,828 | 2,534 | $155,988 | $89,430 |
| 2022 | 32 | 2,254 | 3,306 | $186,795 | $101,573 |
| 2021 | 34 | 4,176 | 5,277 | $250,319 | $146,744 |
| 2020 | 28 | 2,240 | 3,348 | $189,952 | $88,522 |
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 286 | $47,190 | $23,632 | 50.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 138 | $25,530 | $18,061 | 70.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $16,470 | $15,737 | 95.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $5,940 | $4,973 | 83.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 60 | 60 | $5,400 | $4,309 | 79.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 190 | 428 | $4,280 | $3,595 | 84.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 131 | 173 | $8,650 | $2,848 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 68 | 70 | $2,450 | $2,111 | 86.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 144 | 193 | $6,948 | $1,998 | 28.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 122 | 151 | $6,342 | $1,981 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 28 | $3,220 | $1,798 | 55.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 140 | 187 | $4,488 | $1,423 | 31.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 98 | 137 | $2,055 | $1,211 | 58.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 64 | 64 | $1,728 | $1,183 | 68.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 68 | 101 | $2,020 | $961.52 | 47.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 22 | $2,090 | $638.22 | 30.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 35 | 41 | $2,050 | $605.98 | 29.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 45 | $2,925 | $471.91 | 16.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $480.00 | $470.40 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 120 | 148 | $2,220 | $325.60 | 14.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 17 | 19 | $950.00 | $273.79 | 28.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $550.00 | $235.23 | 42.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 20 | 23 | $736.00 | $190.67 | 25.9% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 12 | $360.00 | $177.32 | 49.3% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 25 | 28 | $448.00 | $117.04 | 26.1% |
About Dr. Amy Trace, MD
Dr. Amy Trace, MD is a Internal Medicine healthcare provider based in Warrenton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841308566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Trace, MD has received a total of $5,459 in payments from pharmaceutical and medical device companies, with $493.66 received in 2024. These payments were reported across 363 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($5,436).
As a Medicare-enrolled provider, Trace has provided services to 10,498 Medicare beneficiaries, totaling 14,465 services with total Medicare billing of $426,269. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Warrenton, VA
- Active Since 08/25/2006
- Last Updated 11/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841308566
Products in Payments
- Ozempic (Drug) $468.01
- XARELTO (Drug) $317.17
- Prolia (Biological) $199.53
- NEXLIZET (Drug) $193.61
- JANUVIA (Drug) $173.49
- XIFAXAN (Drug) $170.98
- Trintellix (Drug) $156.70
- INVOKANA (Drug) $150.35
- TRULICITY (Drug) $137.12
- Aimovig (Biological) $128.80
- VRAYLAR (Drug) $123.53
- TOUJEO (Drug) $120.10
- Victoza (Drug) $119.23
- DEXCOM G7 GSS (161) (Medical Supply) $119.00
- Wegovy (Drug) $110.46
- PREVNAR 20 (Biological) $108.28
- UBRELVY (Drug) $105.49
- CHANTIX (Drug) $83.96
- Rybelsus (Drug) $79.31
- ELIQUIS (Drug) $79.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Warrenton
Dr. Robert Lin, Md, MD
Internal Medicine — Payments: $14,557
Joseph David, M.d, M.D
Internal Medicine — Payments: $13,325
Jae Lee, M.d, M.D
Internal Medicine — Payments: $10,293
Dr. Michael Ackerman, D.o, D.O
Internal Medicine — Payments: $7,460
Monica Kanal, D.o, D.O
Internal Medicine — Payments: $6,971
Demetrius Maoury, M.d, M.D
Internal Medicine — Payments: $4,034